Back
IDEXX Laboratories, Inc. (IDXX)
Health CareIDXX · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$550.27
−1.71%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$13.08
ROE
72.9%
Gross margin
62.1%
Debt/Equity
0.71x
Revenue growth
14.3%
IDEXX Laboratories, Inc. — company intelligence
Earnings surprises
Q2 2026$4.27 vs $4.02 est+6.2%
Q1 2026$3.47 vs $3.47 est+0.1%
Q4 2025$3.08 vs $2.99 est+3.1%
Q3 2025$3.40 vs $3.19 est+6.5%
Analyst consensus · 22 analysts
14 Buy8 Hold0 Sell
Updated Aug 13, 2026
Insider activity · 90 days
1 buy2 sellsnet -321 shares
Emerson AndrewSell 86 · Aug 20, 2026
Emerson Andrewother 265 · Aug 20, 2026
HOOLEY JOSEPH LBuy 49 · Jul 30, 2026
Recent SEC filings
4 — Insider transaction reportAug 24, 2026
8-K — Material event reportAug 4, 2026
10-Q — Quarterly reportAug 4, 2026
Latest news
IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day Transcript — SeekingAlpha · 1w ago
IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution — SeekingAlpha · 1w ago
Zoetis: A Solid Long-Term Buy After Harsh Drawdown — SeekingAlpha · 1w ago
IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day - Slideshow — SeekingAlpha · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.